🇺🇸 FDA
Patent

US 7304080

Substituted 1,2,4-oxadiazoles, compositions and methods of use

granted A61KA61K31/4245A61K31/4439

Quick answer

US patent 7304080 (Substituted 1,2,4-oxadiazoles, compositions and methods of use) held by PTC THERAPEUTICS, INC. expires Mon Nov 29 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
PTC THERAPEUTICS, INC.
Grant date
Tue Dec 04 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 29 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K31/4245, A61K31/4439, A61K31/454, A61K31/4545